Repeat gamma knife radiosurgery for refractory or recurrent trigeminal neuralgia: treatment outcomes and quality-of-life assessment

2004 ◽  
Vol 59 (1) ◽  
pp. 112-116 ◽  
Author(s):  
Joseph M Herman ◽  
Joshua H Petit ◽  
Pradip Amin ◽  
Young Kwok ◽  
Pinaki R Dutta ◽  
...  
Author(s):  
Henri Knafo ◽  
Brendan Kenny ◽  
David Mathieu

Background:Trigeminal neuralgia (TN) often remains difficult to treat despite multiple available medications, and can severely impact on the quality of life of affected patients. Gamma knife radiosurgery has recently emerged as a minimally-invasive alternative to surgery for patients suffering from drug-resistant TN. The goal of this study was to report the short-term efficacy of gamma knife radiosurgery for TN and assess its impact on the quality of life of patients treated in the first 18 months of our experience.Methods:Patients with medically-refractory TN or with unacceptable drug side effects were considered for radiosurgery. A maximum dose of 80 Gy was administered to the affected nerve using a single 4-mm isocenter. Follow-up assessments were made at 2, 4 and 6 months, with evaluation of pain relief, drug reduction and quality of life. Factors impacting treatment response were assessed using Cox regression analysis.Results:A total of 67 patients were treated. Significant pain relief was seen in 77.6% of patients, including 32.6% who became pain-free. Patients were able to discontinue all medications in 34.3% or reduce drug intake by more than 50% in an additional 28.4% of cases. No variable was found to predict pain relief although older age (>66 years) approached statistical significance. Sensory side effects were seen in 14.9% of patients. Quality of life improved in the majority of patients after radiosurgery.Conclusions:Gamma knife radiosurgery is a safe and effective management alternative for trigeminal neuralgia, providing good or excellent pain relief and improvement in quality of life in the majority of patients with few side effects.


2018 ◽  
Vol 110 ◽  
pp. e776-e785 ◽  
Author(s):  
Filippo Gagliardi ◽  
Alfio Spina ◽  
Michele Bailo ◽  
Nicola Boari ◽  
Andrea Cavalli ◽  
...  

2009 ◽  
Vol 111 (2) ◽  
pp. 174-178 ◽  
Author(s):  
Mazyar Azar ◽  
Seyyed Taha Yahyavi ◽  
Mohammad Ali Bitaraf ◽  
Farid Kazemi Gazik ◽  
Mahmoud Allahverdi ◽  
...  

2018 ◽  
Vol 109 ◽  
pp. e531-e538 ◽  
Author(s):  
Hongyang Zhao ◽  
Yin Shen ◽  
Dongxiao Yao ◽  
Nanxiang Xiong ◽  
Ahmed Abdelmaksoud ◽  
...  

Neurosurgery ◽  
2008 ◽  
Vol 63 (5) ◽  
pp. 915-924 ◽  
Author(s):  
Andrew S. Little ◽  
Andrew G. Shetter ◽  
Mary E. Shetter ◽  
Curt Bay ◽  
C. Leland Rogers

Abstract OBJECTIVE The long-term outcome of patients treated with gamma knife radiosurgery (GKRS) for typical trigeminal neuralgia has not been fully studied. We evaluated 185 patients who underwent their first GKRS treatment between 1997 and 2003 at the Barrow Neurological Institute. METHODS Follow-up was obtained by surveys and review of medical records. Outcomes were assessed by the Barrow Neurological Institute Pain Intensity Score and Brief Pain Inventory. The most common maximum dose was 80 Gy targeted at the root entry zone. Outcomes are presented for the 136 (74%) patients for whom more than 4 years of clinical follow-up data were obtained. RESULTS Treatment failed in 33% of the cohort within 2 years, but only an additional 1% relapsed after 4 years. Actuarial analysis demonstrated that 32% of patients were pain-free off medication and 63% had at least a good outcome at 7 years. When GKRS was used as the primary treatment, 45% of the patients were pain-free at 7 years. In contrast, 10% of patients in whom previous treatment had failed were pain-free. When needed, salvage therapy with repeat GKRS, microvascular decompression, or percutaneous lesioning was successful in 70%. Posttreatment facial numbness was reported as very bothersome in 5%, most commonly in patients who underwent another invasive treatment. After GKRS, 73% reported that trigeminal neuralgia had no impact on their quality of life. CONCLUSION GKRS is a reasonable long-term treatment option for patients with typical trigeminal neuralgia. It yields durable pain control in a majority of patients, as well as improved quality of life with limited complications and it does not significantly affect the efficacy of other surgical treatments, should they be needed.


Author(s):  
Makarova E. V. ◽  
◽  
Krysanov I. S. ◽  
Vasilyeva T. P. ◽  
Alexandrova O. Yu. ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document